Plus Therapeutics PSTV is set to give its latest quarterly earnings report on Thursday, 2024-11-14. Here's what investors need to know before the announcement.
Analysts estimate that Plus Therapeutics will report an earnings per share (EPS) of $-0.56.
The announcement from Plus Therapeutics is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
Earnings Track Record
The company's EPS missed by $0.18 in the last quarter, leading to a 1.41% drop in the share price on the following day.
Here's a look at Plus Therapeutics's past performance and the resulting price change:
| Quarter | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| EPS Estimate | -0.53 | -1.09 | -1.07 | -1.12 |
| EPS Actual | -0.71 | -0.75 | -0.70 | -1 |
| Price Change % | -1.0% | -3.0% | -11.0% | 6.0% |
Plus Therapeutics Share Price Analysis
Shares of Plus Therapeutics were trading at $1.29 as of November 12. Over the last 52-week period, shares are down 42.66%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.
To track all earnings releases for Plus Therapeutics visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
